表 3. Difference in serological indicators between the two groups before and after treatment.

两组患者治疗前后血清学相关指标的差异

Factor		Research group (n = 76)	Control group (n = 76)	t	P
vWF: von Willebrand factor; Hs-CRP: hypersensitive C-reactive protein; TNF-α: tumour necrosis factor-α; IL-6: interleukin-6; IL-8: interleukin-8; MMP-9: matrix metallopeptidase 9; Hcy: homocysteine; SOD: superoxide dismutase; ∆ = (Post － Pre). * P < 0.001, vs. Pre.
vWF/(pg/mL)	Pre	19.91 ± 2.90	20.13 ± 3.09	－	－
	Post	20.17 ± 3.43	20.07 ± 3.43	－	－
	∆	0.26 ± 4.69	－0.06 ± 4.80	0.575	0.566
Hs-CRP/(mg/L)	Pre	29.34 ± 5.40	30.53 ± 5.59	－	－
	Post	11.35 ± 3.71*	20.33 ± 5.19*	－	－
	∆	－17.99 ± 6.25	－10.20 ± 7.86	－9.385	< 0.001
TNF-α/(μg/L)	Pre	4.54 ± 0.87	4.51 ± 0.88	－	－
	Post	1.97 ± 0.60*	3.74 ± 0.72*	－	－
	∆	－2.57 ± 1.10	－0.77 ± 1.13	－14.066	< 0.001
IL-6/(pg/mL)	Pre	13.07 ± 2.85	12.93 ± 3.30	－	－
	Post	10.50 ± 3.05*	11.99 ± 2.88*	－	－
	∆	－2.57 ± 4.13	－0.94 ± 4.29	－3.384	< 0.001
IL-8/(pg/mL)	Pre	86.44 ± 18.91	82.67 ± 19.04	－	－
	Post	57.92 ± 20.91*	62.98 ± 18.25*	－	－
	∆	－28.52 ± 25.61	－19.69 ± 26.92	－2.931	0.004
MMP-9/(μg/L)	Pre	165.80 ± 12.60	167.34 ± 13.27	－	－
	Post	159.80 ± 11.70*	165.99 ± 12.72	－	－
	∆	－6.00 ± 17.45	－1.35 ± 17.47	－2.318	0.021
Hcy/(μmol/L)	Pre	24.35 ± 3.94	24.45 ± 3.79	－	－
	Post	11.35 ± 2.16*	18.50 ± 3.87*	－	－
	∆	－13.00 ± 4.58	－5.95 ± 5.32	－12.385	< 0.001
SOD/(U/L)	Pre	105.85 ± 14.52	106.47 ± 14.82	－	－
	Post	121.57 ± 11.48*	120.91 ± 11.85*	－	－
	∆	15.72 ± 18.02	14.44 ± 19.58	0.591	0.555